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Introduction
The enantioselective synthesis of pyrrolidines or proline derivatives constitutes a very important trend in organic chemistry due to the interest of them in many scientific fields.
1 Since the biological and medicinal point of view, molecules possessing antibiotic, antitumor, analgesic, neuroexcitatory activities, etc., have been widely described. However, the development of antiviral compounds (commercially available or in clinical survey) constitutes one of the main applications of these skeletons. 2, 3 At this moment, many antiviral agents (used individually or in combination with another drugs) administrated to patients include a nitrogenated five-membered ring, for example, elbasvir, grazoprevir, velpatasvir, ombitasvir, paritaprevir, boceprevir, telaprevir and daclatasvir have been recently developed. 4 The complex skeleton of these molecules contrast with a family of prolinate derivatives 1-3 ( Figure 1 ) reported by GSK through successive evolutions. 5 These compounds act as polymerase inhibitors of the several strands of the virus responsible of the Hepatitis C. Besides, less amount of effective doses and reduced secondary effects converted these products in a promising treatment for hepatitis C virus (HCV) infected people. Binap-gold(I) complex, 10 respectively, was developed. In both routes, the overall yields obtained were moderate to good and enantioselectivities were very high, especially in the case of the 2 nd generation inhibitor (99% ee). In this work, we report the efforts dedicated to build enantioselectively the core heterocyclic ring precursor of the GSK 625433 polymerase inhibitor 3 12 and also a brief study of the scope and versatility of the new developed catalyst will be disclosed.
Results and discussion
According to the classical retrosynthetic analysis of this family of compounds, we envisaged that the enantiomerically enriched cycloadducts endo-4 type were the key compounds to the access to antiviral agent 3. Initially, we designed two alternative approaches where the pyrazole ring was bonded in the starting imino ester (Scheme 1, eq. a) and a second retrosynthesis in which the pyrazole was introduced once the 1,3-DC occurred (Scheme 1, eq. b). Starting imino ester 5a could be generated, under mild conditions, from commercially available 3-(1-pyrazolyl)-L-alanine methyl ester hydrochloride but important amounts of the product, resulting from the β-elimination of pyrazole, were detected by 1 H NMR spectroscopy. The non-asymmetric multicomponent 1,3-DC was then tested employing tert-butyl acrylate, 2-thiazolecarbaldehyde and the amino ester, furnishing the undesirable β-elimination product. 13 This problem was overcome employing the route starting from O-TBDMS serine derivative (Scheme 1, eq. b). Stable imino ester 5b was much more appropriate to run the non-asymmetric cycloaddition and, in consequence, adequate to survey the enantioselective 1,3-DC. This imino ester 5b was obtained, in almost quantitative yield, by reaction of 2-thiazolecarbaldehyde with the known compound O-TBDMS serine methyl ester 14 in DCM at room temperature for 19 h and it was employed in the cycloadditions without any other purification (see experimental part).
Scheme 1. Retrosynthetic analysis.
Many chiral ligands and silver salts were tested in 5 mol% loading (Scheme 2 and Table 1 ) but always using toluene as better solvent (not registered in Table 1 ). The cycloadditions performed at room temperature involving Binap 6 afforded very good conversions but with moderate enantioselections (Table 1 , entries 1-3). 15 The best silver salt was AgSbF6, which gave, at room temperature, the desired compound endo-4b as a 85:15 mixture of diastereoisomers in 85:15 enantiomeric ratio (Table 1 , entry 2). The lowering of the temperature was not beneficial for this transformation (Table 1, entry 3) . 16 Chiral ligands 7 and 8 did not improve the results achieved by Binap 6 and almost racemic compound endo-4b was isolated when AgOBz or AgSbF6 were combined with chiral ligands 9-13 (these results are not included in Table 1 ). Phosphoramidite (Sa,R,R)-14·AgTFA complex and the analogous one formed with AgSbF6 furnished identical conversions, diastereomeric and enantiomeric ratios (Table 1 , entries 4 and 5). The analysis of the temperature was next studied (Table 1 , entries 5-7) obtaining an increment of the diastereomeric ratio (up to 99:1, at -80 ºC) but with a moderate enantioselection (80:20 at the same temperature). Analogous H8-chiral complex 15·AgSbF6 was not suitable for inducing a very high enantiodiscrimination (Table 1 , entry 8). Because of dimeric gold species (S,S)-16·TFA2 was effective in the synthesis of the second generation GSK-agents it was used at 0 ºC in the cycloaddition of tert-butyl acrylate and imino ester 5b. The reaction was almost complete after 48 h reaction time giving endo-4b as major diastereoisomer in 85:15 dr and modest enantioselection (78:26 er, Table 1 , entry 9). (S,S)-16·(OBz)2 catalytic complex was not effective affording lower diastereomeric and enantiomeric ratios (Table 1 , entry 10). However, the dual chiral catalyst 14·Ag-(R)-17, formed by reaction of silver carbonate and chiral (R)-binol-phosphoric acid in toluene 17 for 1 h followed by the addition of phosphoramidite 14, produced at room temperature endocycloadduct 4b in excellent conversion and high diasteromeric and enantiomeric ratio (Table 1,  entry 11) . A lowering of the temperature to -20 ºC did not produce any significant amelioration of the enantiomeric ratio. The corresponding enantiomer ent-endo-4b was easily obtained by employing the enantiomeric chiral catalytic system such as it is shown in entry 12 of Table 1 . The configuration of these two enantiomeric forms of the dual chiral silver complex resulted to be the matched combination for this transformation because the other two detailed in the last two entries of Table 1 afforded lower enantiomeric ratios although with excellent conversions. From these three last entries, the absolute configuration induced in cycloadducts is strongly dependent of the axial chirality of the phosphoramidite ligand.
7 Scheme 2. Chiral ligands employed in the optimization study. With compound endo-4b in hand (82% yield, 96:4 dr and 92:7 er) next three steps were carried out in a sequential manner (Scheme 3). First, TBDMS was removed using three equiv. of tetrabutylammonium fluoride (TBAF, 1 M solution in THF) at room temperature for 3 h. Mesylation of the alcohol in the absence of trimethylamine avoided undesirable ring expansion process and after 2 h at 0 ºC, sodium pyrazolide 18 was added at 0 ºC. Cycloadduct endo-18 was isolated after flash chromatography in 32% overall yield from endo-4b. The final access to molecule 3 can be achieved following known procedures described for this family of HCV inhibitors. The determination of the absolute configuration and the scope of effectiveness of the double chiral activated complex 14·Ag-(R)-17 were studied simultaneously. Initially, Nmethylmaleimide (NMM) was allowed to react with imino ester 19 (Ar = Ph, R 1 = H) under optimized reaction conditions yielding product 20a ( Table 2 , entry 1). The absolute configuration was assigned on the basis on the comparison of its retention time (HPLC using a chiral stationary phase column) with the retention time of the identical sample isolated from the reaction catalyzed by 14·AgClO4 complex. 8 This absolute configuration was confirmed by analyzing both HPLC and specific optical rotation data of all isolated compounds described in Table 2 . The dual chiral catalyst 14·Ag-(R)-17 and 14·AgClO4 chiral complex afforded similar results of 20b and 20c too ( Table 2 , entries 2 and 3). However, the presence of a substituent at the α-position of the imino ester 19 caused steric difficulties to the bulky chiral entity of 14·Ag-(R)-17. Thus, when alanine, leucine and phenylalanine derived imino esters 19 were employed with different dipolarophiles the catalytic complex 14·AgClO4 afforded cycloadducts 20 in higher both diastereomeric and enantiomeric ratios, although chemical yields are similar using separately both catalytic complexes ( Table 2 , entries 4-6). It is noteworthy that compound 20d appeared as potential novel HIV-1 integrase inhibitor, 20 and molecule 20e is the key building block for the synthesis of the HCV inhibitor 1.
6,8
Scheme 4. Scope of the reaction. 
Conclusions
In this work, the modulation of the chiral catalyst 14·Ag-(R)-17 could be adapted to the effective approach of the imino ester and tert-butyl acrylate to access the enantiomerically enriched core of the antiviral agent GSK 625433 by first time. Dual chiral catalyst is very appropriate to achieve a high enantioselection in this transformation unlike to the result gave by 14·AgClO4 complex. In the case of glycine imino esters both catalysts exhibit a similar behavior in the enantioselective 1,3-DC with dipolarophiles, but for sterically hindered imino esters (derived from α-substituted amino acids) it is advisable the employment of 14·AgClO4 complex.
Experimental Part

General information
Melting points were determined with a Reichert Thermowar hot plate apparatus and are uncorrected. Only the structurally most important peaks of the IR spectra (recorded whit a FT-IR 4100LE (JASCO) (PIKE MIRacle ATR) are listed.
1 H NMR (300 MHz) and 13 C NMR (75 MHz) spectra were obtained with a Bruker AC-300 by using CDCl3 as solvent and TMS as the internal standard, unless otherwise stated. Optical rotations were measured with a JASCO 2000 series. HPLC analyses were performed with a JASCO-2000 series equipped with a chiral stationary phase column (detailed for each compound in the main text) by using mixtures of n-hexane/isopropyl alcohol as the mobile phase at 25 ºC. Low-resolution electron impact (EI) mass spectra were obtained with a Shimadzu QP-5000 by injection or DIP, and high-resolution mass spectra were obtained with a Finnigan VG Platform or a Finnigan MAT 95S. Analytical TLC was performed on Schleicher & Schuell F1400/LS 254 silica gel plates and the spots were visualized under UV light (λ = 254 nm). Merck silica gel 60 (0.040-0.063 mm) was used for flash chromatography.
Synthesis of imino ester 5b.
In a 10 mL flask was dissolved free O-TBDMS serine methyl ester 14 (357 mg, 1.5 mmol) and 2-thiazolecarbaldehyde (134 μL, 1.5 mmol) in anhydrous dichloromethane (10 mL) and magnesium sulfate (200 mg) was added. The reaction was stirred at room temperature overnight and the organic phase was washed with bine, dried and evaporated affording quantitatively the crude imine (492 mg, 1. In a 10 ml vial covered by aluminum foil, Ag2CO3 (2.8 mg, 0.01 mmol), (R)-Binol-phosphoric acid (7 mg, 0.02 mmol) and toluene (3 mL) were added and the resulting mixture was stirred at room temperature for 1 h. Phosphoramidite (Sa,R,R)-14 (10.8 mg, 0.02 mmol) was added and the reaction stirred for additional 40 min. Then, the imino ester (0.4 mmol), the dipolarophile (0.4 mmol) and triethylamine (3 μL, 0.02 mmol) were added in this order and the reaction stirred at room temperature. The mixture was cooled at -10 ºC and the amino ester 2c (193 mg, 1 mmol), the corresponding maleimide 3 (1 mmol), and ethyl glyoxylate 1 (ca.50% solution in toluene, 102 μL, 1.2 mmol) were slowly added in this order. The reaction was stirred for 17 h. The solvent was evaporated and the crude product was purified purified by flash chromatography (nhexane:EtOAc), affording cycloadducts endo-4b and 20. Compound endo-4b (264 mg, 0.58 mmol) was dissolved in anhydrous in THF and tetrabutylammonium fluoride (1M solution in THF) was added (1.75 mL, 1.75 mmol) at 0 ºC, and the reaction was stirred at room temperature for three hours. The solvent was evaporated and ethyl acetate (10 mL) was added. The resulting solution was washed with bine, died and evaporated affording the intermediate alcohol, which was dissolved in anhydrous THF (5 mL). This new solution was cooled at 0 °C, triethylamine (89 μL, 0.64 mmol) was added and methanesulfonyl chloride was slowly introduced (54 μL, 0.64 mmol) and stirring continued for two hours at the same temperature. At this moment, a 1:1 anhydrous DMF:THF solution (3 mL) containing sodium pyrazolide [1.75 mmol, obtained by mixing pyrazole (118 mg, 1.75 mmol) with sodium hydride (95%, 42 mg, 1,75 mmol)] was added and the reaction stirred at room temperature for 24 h. The solvent was evaporated and the residue purified by flash chromatography (nhexane:EtOAc), affording cycloadduct endo-18 as a pale yellow oil (70 mg, 32% overall yield 
